Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
13-13-1|Sr-Gl-Bq 0,n/a|1|75|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (0 in ERA)|Mouse|Mouse, C57BL|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
13-13-2|Sr+Gl150-250-Bq 0,n/a|1|225|glucane|1.6|milligrams|Injection, intraperitoneal|for 100 d 2w interval|50 (0 in ERA)|Mouse|Mouse, C57BL|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
13-13-3|Sr+Gl250-350-Bq 0,n/a|1|325|glucane|1.6|milligrams|Injection, intraperitoneal|for 100 d 2w interval|50 (0 in ERA)|Mouse|Mouse, C57BL|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
13-13-4|Sr-Gl-Bq 14.8,n/a|1|75|Sr-90 nitrate|14.8|kilobecquerels per g animal|Injection, intraperitoneal|single injection|50 (0 in ERA)|Mouse|Mouse, C57BL|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
13-13-5|Sr+Gl150-250-Bq 14.8,n/a|1|75|Sr-90 nitrate|14.8|kilobecquerels per g animal|Injection, intraperitoneal|single injection|50 (0 in ERA)|Mouse|Mouse, C57BL|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
13-13-5|Sr+Gl150-250-Bq 14.8,n/a|2|225|glucane|1.6|milligrams|Injection, intraperitoneal|for 100 d 2w interval|50 (0 in ERA)|Mouse|Mouse, C57BL|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
13-13-6|Sr+Gl250-350-Bq 14.8,n/a|1|75|Sr-90 nitrate|14.8|kilobecquerels per g animal|Injection, intraperitoneal|single injection|50 (0 in ERA)|Mouse|Mouse, C57BL|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
13-13-6|Sr+Gl250-350-Bq 14.8,n/a|2|325|glucane|1.6|milligrams|Injection, intraperitoneal|for 100 d 2w interval|50 (0 in ERA)|Mouse|Mouse, C57BL|Male|Young Adult|Lifespan study macro/microscopic pathology|No information on individuals available for this study
